CIRM Funded Clinical Trials
Inhibitory Interneuron Cell Therapy (NRTX-1001) for the Treatment of Drug-resistant Bilateral Temporal Lobe Epilepsy
Disease Area:
Epilepsy
Trial Sponsor:
Neurona Therapeutics
Trial Stage:
Phase 1/2
Trial Status:
Launching
Targeted Enrollment:
N/A
